The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family - PubMed (original) (raw)
Comparative Study
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
H E Van Wart et al. Proc Natl Acad Sci U S A. 1990 Jul.
Abstract
The general applicability of the "cysteine-switch" activation mechanism to the members of the matrix metalloproteinase (MMP) gene family is examined here. All currently known members of the MMP gene family share the characteristic that they are synthesized in a latent, inactive, form. Recent evidence suggests that this latency in human fibroblast collagenase (HFC) is the result of formation of an intramolecular complex between the single cysteine residue in its propeptide domain and the essential zinc atom in the catalytic domain, a complex that blocks the active site. Latent HFC can be activated by multiple means, all of which effect the dissociation of the cysteine residue from the complex. This is referred to as the "cysteine-switch" mechanism of activation. The propeptide domain that contains the critical cysteine residue and the catalytic domain that contains the zinc-binding site are the only two domains common to all of the MMPs. The amino acid sequences surrounding both the critical cysteine residue and a region of the protein chains containing two of the putative histidine zinc-binding ligands are highly conserved in all of the MMPs. A survey of the literature shows that many of the individual MMPs can be activated by the multiple means observed for latent HFC. These observations support the view that the cysteine-switch mechanism is applicable to all members of this gene family. This mechanism is unprecedented in enzymology as far as we know and offers the opportunity for multiple modes of physiological activation of these important enzymes. Since conditions in different cells and tissues may match those necessary to effect one of these activation modes for a given MMP, this may offer metabolic flexibility in the control of MMP activation.
Similar articles
- Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.
Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE. Springman EB, et al. Proc Natl Acad Sci U S A. 1990 Jan;87(1):364-8. doi: 10.1073/pnas.87.1.364. Proc Natl Acad Sci U S A. 1990. PMID: 2153297 Free PMC article. - Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch".
Park AJ, Matrisian LM, Kells AF, Pearson R, Yuan ZY, Navre M. Park AJ, et al. J Biol Chem. 1991 Jan 25;266(3):1584-90. J Biol Chem. 1991. PMID: 1988438 - APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
Galazka G, Windsor LJ, Birkedal-Hansen H, Engler JA. Galazka G, et al. Biochemistry. 1996 Aug 27;35(34):11221-7. doi: 10.1021/bi960618e. Biochemistry. 1996. PMID: 8780527 - Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF Jr. Woessner JF Jr. FASEB J. 1991 May;5(8):2145-54. FASEB J. 1991. PMID: 1850705 Review. - Matrix metalloproteinases: fold and function of their catalytic domains.
Tallant C, Marrero A, Gomis-Rüth FX. Tallant C, et al. Biochim Biophys Acta. 2010 Jan;1803(1):20-8. doi: 10.1016/j.bbamcr.2009.04.003. Epub 2009 Apr 15. Biochim Biophys Acta. 2010. PMID: 19374923 Review.
Cited by
- Regulated cleavage and translocation of FERONIA control immunity in Arabidopsis roots.
Chen J, Xu F, Qiang X, Liu H, Wang L, Jiang L, Li C, Wang B, Luan S, Wu D, Zhou F, Yu F. Chen J, et al. Nat Plants. 2024 Oct 14. doi: 10.1038/s41477-024-01823-8. Online ahead of print. Nat Plants. 2024. PMID: 39402220 - Unlocking the Potential of Collagenases: Structures, Functions, and Emerging Therapeutic Horizons.
Wang ZZ, Wang K, Xu LF, Su C, Gong JS, Shi JS, Ma XD, Xie N, Qian JY. Wang ZZ, et al. Biodes Res. 2024 Oct 8;6:0050. doi: 10.34133/bdr.0050. eCollection 2024. Biodes Res. 2024. PMID: 39381623 Free PMC article. - Machine learning in preclinical drug discovery.
Catacutan DB, Alexander J, Arnold A, Stokes JM. Catacutan DB, et al. Nat Chem Biol. 2024 Aug;20(8):960-973. doi: 10.1038/s41589-024-01679-1. Epub 2024 Jul 19. Nat Chem Biol. 2024. PMID: 39030362 Review. - Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease.
Vilardi A, Przyborski S, Mobbs C, Rufini A, Tufarelli C. Vilardi A, et al. Cell Death Discov. 2024 May 27;10(1):258. doi: 10.1038/s41420-024-02015-1. Cell Death Discov. 2024. PMID: 38802341 Free PMC article. Review. - Modification of extracellular matrix proteins by oxidants and electrophiles.
Yang-Jensen KC, Jørgensen SM, Chuang CY, Davies MJ. Yang-Jensen KC, et al. Biochem Soc Trans. 2024 Jun 26;52(3):1199-1217. doi: 10.1042/BST20230860. Biochem Soc Trans. 2024. PMID: 38778764 Free PMC article. Review.
References
- Eur J Biochem. 1990 Apr 30;189(2):295-300 - PubMed
- Nucleic Acids Res. 1986 Jul 25;14(14):5843-55 - PubMed
- Science. 1973 Jun 8;180(4090):1022-7 - PubMed
- J Biol Chem. 1987 Apr 25;262(12):5886-9 - PubMed
- Gene. 1986;49(3):303-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources